Navigation Links
Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
Date:11/19/2008

and a predecessor investment bank, Hambrecht & Quist). From 1981 to 1996, he held positions, including partner, at several law firms including Cooley Godward LLP, Sidley Austin LLP and Davis Polk & Wardwell. He serves as a member of the board of directors and is chairman of the audit committee of Anacor Pharmaceuticals, Inc. Mr. Cleveland holds a J.D. from Northwestern University School of Law and an A.B. from Washington University in St. Louis.

"I am excited to join the board of directors of Sangamo BioSciences at this point in the company's development," commented Mr. Cleveland. "Sangamo has a successful business model designed to maximize the value of its ZFP technology platform by partnering non-core areas of its business as well as looking to establish new corporate partnerships in core ZFP Therapeutics. I look forward to contributing my experience to help position the company for continued growth and success."

About Sangamo

Sangamo BioSciences, Inc. is focused on the research and development of novel DNA-binding proteins for therapeutic gene regulation and modification. The most advanced ZFP Therapeutic(TM) development program is currently in Phase 2 clinical trials for evaluation of safety and clinical effect in patients with diabetic neuropathy and ALS. Other therapeutic development programs are focused on cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established strategic partnerships wit
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
2. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
3. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
4. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
5. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
6. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
7. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
8. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
9. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
10. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
11. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., VIENNA, Austria, November 6 /PRNewswire/ -...izing, manufacturing, and marketing enzymes for th...tered into a research,agreement with Bio Sidus, th...ca. , The agreement gives EUCODIS Bioscie...f interest - to Bio Sidus, proprietary collection ...
(Date:11/6/2009)... The agenda for Arrowhead&r...ference, which is set to take place on February 22...this three day conference we will highlight key is...peakers to share their experiences. , ...009 -- The agenda for Arrowhead’s 2010 Pers...
(Date:11/5/2009)..., SAN DIEGO, Nov. 5 Im...ed today that William Spencer, President and CEO o...ry at the 2nd annual LD MICRO Conference on Thursd...et in Los Angeles. ,, About LD MICRO ,, LD M...focuses on finding undervalued companies in the mi...
(Date:11/5/2009)..., SUNNYVALE, Calif., Nov. 5 /PRNewswire-FirstCal...t its executives will be speaking at the following...rticipate via webcast. , , Credit ... Thursday, 12 November, 2009 at 10 a.m. Mo...stor Program, London, England, Tue...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Cepheid to Webcast Upcoming Financial Presentations 2
... Now that Christopher Chitambar, a physician resea... Center, has found that a gallium compound might b... test. , ,If the compound is found to be safe and ... treat forms of non-Hodgkin,s lymphoma that are re...ma is a cancer of the human lymphatic system, whic...
... The latest piece of the University of Wisconsin-...ness community is in place. With the help of two c...nched the UWM Research Foundation, a fund-raising ...e foundation, which has been in the works for abou...ing from both Wisconsin Energy Corp . and Harley...
...red Robertson doesn,t pretend to be a fortune tell...ll be setting the standard in radiation therapy fo... officer of TomoTherapy, exudes confidence that th...latform, will continue to be a competitive differe...s, or incremental treatments, have been delivered ...
Other Biology Technology:Cancer-fighting agent heads for clinical trials 2UWM launches research foundation 2TomoTherapy sees sustained market advantage 2TomoTherapy sees sustained market advantage 3TomoTherapy sees sustained market advantage 4
(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...
(Date:11/4/2009)... United States Using Less Water Today , The Un...ears ago, despite a 30 percent population increase... alternative cooling methods at power plants and m... latest USGS water use report, nearly half of all ...ermoelectric power plants. Irrigation accounts for...
(Date:11/4/2009)..., hold the power to help militaries and munitions ...ic waste on test sites. , Compounds known as nit...orld War II and have been used in military munitio...ften used to propel tank shells and act like a mor...d knowledge of their environmentally harmful effec...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 1Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 2Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 3Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 4Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 5Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 6Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 7Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 8Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 9Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 10Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 11Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 12Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 13Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 59162 14Toxic Chemicals Found in Doctors and Nurses 59159 1Toxic Chemicals Found in Doctors and Nurses 59159 2CardioDx Announces Appointment of Dr Louis G Lange as Chairman of the Board of Directors 14398 1CardioDx Announces Appointment of Dr Louis G Lange as Chairman of the Board of Directors 14398 2CardioDx Announces Appointment of Dr Louis G Lange as Chairman of the Board of Directors 14398 3
...IA, Mo. About one in 3,500 people are affected wi...ina,s visual cells that eventually leads to blindn...identified a genetic link between cats and humans ... help scientists develop gene-based therapies that...me genetic mutations that cause retinal blindness ...
...rtian volcano Olympus Mons is about three times th...ils that Rice University professors Patrick McGove...ut whether the Red Planet ever had or still suppo...figure out how Olympus Mons came to be, McGovern a...ockets of ancient water may still be trapped under...
...ists at the University of Liverpool have determine...brain protein and an antibody that could be key to...JD. , Variant Creutzfeldt-Jakob Disease (vCJD) is...ative disorders, called prion diseases, which affe...se who have developed vCJD became infected through...
Other Biology News:Cats' eye diseases genetically linked to diseases in humans 2Mountain on Mars may answer big question 2Antibody key to treating variant CJD, scientists find 2
QuantiChrom Bilirubin Assay Kit from BioAssay Systems
Albumin Colorimetric Assay Kit, QuantiChrom from BioAssay Systems
Pyrophosphate Colorimetric / Fluorometric (resorufin) Assay Kit, PiPer from Molecular Probes (Invitrogen)
Mouse/Rat Anti-Canine CD3 / CD4 Dual Colour Reagent Antibody, FITC / R-Phycoerythrin Conjugated from AbD Serotec
Biology Products: